Business Description
B&K Corp Ltd
SIC : 2836
ISIN : CNE100007CT6
Share Class Description:
HKSE:02396: Ordinary Shares- Class HTotal Employee Number:
100Compare
Compare
Traded in other countries / regions
02396.Hong Kong IPO Date
2025-12-22Description
B&K Corp Ltd is a China-based biopharmaceutical company focused on developing protein-based therapies, particularly platelet-derived growth factor (PDGF) drugs. Its pipeline centers on recombinant human PDGF-BB candidates, including Pro-101-1 for thermal burns and Pro-101-2 for diabetic foot ulcers, along with other preclinical and clinical-stage programs. The company operates in a single reportable segment: research and development of biopharmaceutical products. It serves the Chinese healthcare market, with all revenue generated from mainland China. As a clinical-stage company, its revenue model primarily depends on licensing, collaboration agreements, and potential future product commercialization rather than established product sales. The company is headquartered in China and targets indications with significant unmet medical needs in wound healing and regenerative medicine.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 183.22 | |||||
Equity-to-Asset | 0.91 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.05 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 3.93 | |||||
Beneish M-Score | -1.48 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 45.36 | |||||
9-Day RSI | 41.75 | |||||
14-Day RSI | 43.4 | |||||
3-1 Month Momentum % | 7.44 | |||||
6-1 Month Momentum % | -39.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 17.11 | |||||
Quick Ratio | 17.11 | |||||
Cash Ratio | 17.01 | |||||
Days Sales Outstanding | 412.44 | |||||
Days Payable | 77604.16 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 92.03 | |||||
Operating Margin % | -15187 | |||||
Net Margin % | -14266.9 | |||||
EBITDA Margin % | -13768.28 | |||||
FCF Margin % | -15898.55 | |||||
OCF Margin % | -15287.71 | |||||
ROE % | -30.89 | |||||
ROA % | -25.89 | |||||
ROIC % | -135.12 | |||||
ROC (Joel Greenblatt) % | -476.53 | |||||
ROCE % | -28.09 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 839 | |||||
PB Ratio | 0.72 | |||||
Price-to-Tangible-Book | 0.75 | |||||
EV-to-EBIT | 2.97 | |||||
EV-to-EBITDA | 3.06 | |||||
EV-to-Revenue | -421.31 | |||||
EV-to-FCF | 2.65 | |||||
| Price-to-Net-Current-Asset-Value | 0.78 | |||||
| Price-to-Net-Cash | 0.78 | |||||
Earnings Yield (Greenblatt) % | 33.67 | |||||
FCF Yield % | -18.44 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
B&K Corp Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 0.573 | ||
| EPS (TTM) (HK$) | -0.695 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 43.4 | ||
| 14-Day ATR (HK$) | 0.434501 | ||
| 20-Day SMA (HK$) | 4.5415 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (HK$) | 3.5 - 37.2 | ||
| Shares Outstanding (Mil) | 117.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
B&K Corp Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
B&K Corp Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
B&K Corp Ltd Frequently Asked Questions
What is B&K Corp Ltd(HKSE:02396)'s stock price today?
The current price of HKSE:02396 is HK$4.20. The 52 week high of HKSE:02396 is HK$37.20 and 52 week low is HK$3.50.
When is next earnings date of B&K Corp Ltd(HKSE:02396)?
The next earnings date of B&K Corp Ltd(HKSE:02396) is .
Does B&K Corp Ltd(HKSE:02396) pay dividends? If so, how much?
B&K Corp Ltd(HKSE:02396) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers